Medical Research Council (MRC)

This sponsor has funded 6 studies across 14 countries.

PAS funded by this sponsor.
EU PAS ID Status RMP requirement Title Protocol uploaded Results uploaded
4238 Finalised Not included in RMP A RETROSPECTIVE, REAL-LIFE EVALUATION OF THE CARDIOVASCULAR DISEASE RISK ASSOCIATED WITH EXPOSURE TO PHARMACOLOGICAL SMOKING CESSATION INTERVENTIONS... Yes No
36059 Planned Not included in RMP Similarity-based approaches to identifying risk of future asthma attack using UK primary care data No No
38362 Ongoing Not included in RMP The risk of musculoskeletal adverse outcomes after treatment with endocrine blocking treatments for breast cancer (MSKAI) Yes No
45026 Ongoing Not included in RMP COVID-19 in Pregnancy in Scotland COVID-19: vaccine safety analyses in pregnant women (COPS) Yes No
47704 Ongoing Not included in RMP Impact of COVID-19 on Asthma Exacerbations (Asthma Attacks During COVID-19) No No
49055 Planned Not included in RMP Improving detection of associations between congenital anomalies and medicines taken in the first trimester of pregnancy, using data derived... No No

PAS by Risk Management Plan (RMP) requirement

Medical Research Council (MRC)

The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.

Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.